BioRock Ventures invests in
therapeutics startups
Seed-sized investments into private life science companies developing novel FDA regulated therapeutic drugs. Angel, Seed, Series A, through pre-IPO/M&A. All disease areas, all stages, all therapeutic modalities.
Mary Wheeler, PhD, MBA
Managing Director
Mary is founding managing partner of BioRock Ventures in the Bay Area, CA. Mary began two decades of operating experience as a therapeutics startup founder in Boston. She moved to roles leading negotiations, business and technical evaluations for M&A and licensing deals as well as strategy roles at large and medium pharmaceuticals companies like Johnson & Johnson and Forest (now Allergan|Abbvie) in NYC. She also has served as consulting CBO for several dozen early stage ventures around the world. She began venture investing a decade ago where she helped form and put first money into two new companies which each had IPO exits valued over $1 Billion.
Mary is a Kauffman Fellow, earned an MBA from MITSloan, a PhD from Princeton University and an undergraduate degree from Yale University. She enjoys lots of sports including snowboarding and horseback riding.